Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00884 | m-PEG8-Ms | 1059588-19-0 |
| m-PEG8-Ms is a mesylate-activated PEG linker used in antibody-drug conjugates for efficient nucleophilic substitution reactions. Its PEG8 spacer increases hydrophilicity and solubility of payloads, improving bioconjugate stability and pharmacokinetic profiles in targeted therapies. | Inquiry | |
| BADC-00887 | t-Boc-N-amido-PEG4-bromide | 1076199-21-7 |
| t-Boc-N-amido-PEG3-bromide is a PEG linker containing a bromide group and a Boc-protected amino group. The hydrophilic PEG spacer increases solubility in aqueous media. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The Boc group can be deprotected under mild acidic conditions to form the free amine. | Inquiry | |
| BADC-00890 | mPEG4-bromide | 110429-45-3 |
| mPEG4-bromide is a PEG linker containing a bromide group. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The hydrophilic PEG spacer increases solubility in aqueous media. | Inquiry | |
| BADC-00891 | (2-pyridyldithio)-PEG1-hydrazine | 111625-28-6 |
| (2-pyridyldithio)-PEG1-hydrazine is a cleavable ADC linker featuring pyridyl disulfide and hydrazine groups. It facilitates thiol-reactive conjugation and hydrazone chemistry for pH-sensitive payload release in ADC development. | Inquiry | |
| BADC-00892 | N-(Iodoacetamido)-Doxorubicin | 114390-30-6 |
| N-(Iodoacetamido)-Doxorubicin is an ADC payload-linker conjugate featuring iodoacetamide for cysteine-specific attachment, enabling targeted delivery and controlled release in antibody-drug conjugates. Keywords: ADC linker, iodoacetamide linker, doxorubicin payload, cysteine conjugation, targeted therapy. | Inquiry | |
| BADC-00894 | SPDB | 115088-06-7 |
| SPDB (N-Succinimidyl 4-(2-pyridyldithio)butanoate) is a disulfide-containing ADC linker used for reversible thiol conjugation. It supports cleavable drug-antibody coupling, allowing selective release under reductive intracellular conditions, commonly employed in ADC development. | Inquiry | |
| BADC-00895 | Fmoc-N-amido-PEG9-acid | 1191064-81-9 |
| Fmoc-N-amido-PEG9-acid is a high-performance ADC linker featuring a PEG9 spacer that enhances solubility and flexibility. It facilitates efficient and stable drug-antibody conjugation, making it ideal for targeted cancer therapy development. | Inquiry | |
| BADC-00900 | Azido-PEG8-NHS ester | 1204834-00-3 |
| Azido-PEG8-NHS ester enables bioorthogonal click chemistry in ADC linker design, improving conjugation efficiency and stability for targeted antibody-drug conjugates with enhanced pharmacokinetics. | Inquiry | |
| BADC-00903 | NHS-SS-biotin | 122266-55-1 |
| NHS-SS-biotin is a cleavable ADC linker combining NHS ester for amine coupling and disulfide-linked biotin for affinity tagging. Widely used in ADC bioconjugation and targeted drug delivery studies. | Inquiry | |
| BADC-00908 | DBCO-amine | 1255942-06-3 |
| DBCO-amine is a core ADC linker building block with a dibenzocyclooctyne group for copper-free click conjugation, enabling efficient and site-specific antibody-payload attachment in targeted therapies. | Inquiry | |
| BADC-00909 | DBCO-NH-PEG4-amine | 1255942-08-5 |
| DBCO-NH-PEG4-amine is a versatile ADC linker featuring a dibenzocyclooctyne group for copper-free click chemistry. Ideal for antibody-drug conjugate development, it enables efficient bioconjugation via strain-promoted azide-alkyne cycloaddition (SPAAC), enhancing stability and hydrophilicity in targeted drug delivery systems. | Inquiry | |
| BADC-00910 | DBCO-NHCO-PEG4-NH-Boc | 1255942-12-1 |
| DBCO-NHCO-PEG4-NH-Boc is a protected amine-containing ADC linker enabling future payload conjugation via SPAAC. Its PEG4 spacer enhances solubility, while the Boc-protected amine allows orthogonal synthetic strategies in ADC and bioconjugate design. | Inquiry | |
| BADC-00912 | t-Boc-N-amido-PEG1-propionic acid | 1260092-44-1 |
| t-Boc-N-amido-PEG1-propionic acid is a cleavable (1-unit PEG) ADC linker, as well as a PEG- and alkyl/ether-based PROTAC linker that can be used to synthesize antibody-drug conjugates (ADCs) or PROTACs. | Inquiry | |
| BADC-00913 | Bis-PEG9-acid | 1268488-70-5 |
| Bis-PEG9-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Bis-PEG9-acid is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00916 | t-Boc-N-amido-PEG7-alcohol | 1292268-13-3 |
| t-Boc-N-amido-PEG7-alcohol is a protected amine-functionalized PEG linker designed for ADC intermediate synthesis. The PEG7 chain improves solubility and pharmacokinetics, making it suitable for multistep conjugation strategies. | Inquiry | |
| BADC-00917 | Amino-PEG10-alcohol | 129449-09-8 |
| Amino-PEG10-alcohol is a bifunctional PEG linker featuring both amine and alcohol groups, used in ADC linker chemistry for flexible conjugation strategies. Its extended PEG10 spacer increases solubility and minimizes immunogenicity of antibody-drug conjugates. | Inquiry | |
| BADC-00920 | m-PEG4-Ms | 130955-37-2 |
| m-PEG4-Ms provides a shorter mesyl-activated PEG linker option for ADC construction, enhancing payload solubility and reactivity. It enables effective conjugation to nucleophiles, supporting flexible linker design in antibody-drug conjugation and controlled drug release systems. | Inquiry | |
| BADC-00921 | m-PEG5-Ms | 130955-38-3 |
| m-PEG5-Ms is a mesylated monofunctional PEG linker used in ADC construction to facilitate nucleophilic substitution. The PEG5 spacer boosts solubility and stability of conjugates, making it suitable for drug-linker modification and enhancing targeted therapeutic delivery. | Inquiry | |
| BADC-00924 | Bis-PEG7-NHS ester | 1334170-02-3 |
| Bis-PEG7-NHS ester provides a long-chain homobifunctional PEG linker for bioconjugation via NHS ester chemistry. Ideal for constructing highly soluble, flexible ADC linkers with improved drug delivery performance. | Inquiry | |
| BADC-00929 | Fmoc-D-Val-Cit-PAB | 1350456-65-3 |
| Fmoc-D-Val-Cit-PAB is a cleavable ADC linker with Val-Cit dipeptide and PAB spacer, facilitating enzymatic drug release and site-specific antibody conjugation in targeted cancer therapy. | Inquiry |
